Full Company Report
Walgreen Co. is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreens pioneered many store features that are becoming standards in the industry. Among those concepts are: Computerized pharmacies, Point-of-sale scanning, Freestanding stores with drive-thru pharmacies, and Intercom Plus, Walgreens advanced new pharmacy computer and workflow system. Intercom Plus allows pharmacists to spend more time counseling patients by assigning administrative tasks to pharmacy technicians
General Information
WALGREEN CO
108 WILMOT RD
DEERFIELD, IL 60015
Phone: 8479402500
Fax: 847-914-2804
Web: http://www.walgreens.com
Email: investor.relations@walgreens.com
| Industry | RETAIL-DRUG STR |
| Sector | Retail-Wholesale |
| Fiscal Year End | August |
| Last Reported Quarter | 02/28/2013 |
| Next EPS Date | 06/25/2013 |
Price and Volume Information
| Zacks Rank | ![]() |
| Yesterday's Close | 49.07 |
| 52 Week High | 50.35 |
| 52 Week Low | 28.53 |
| Beta | 1.07 |
| 20 Day Moving Average | 5,503,789.00 |
| Target Price Consensus | 46.69 |
% Price Change
| 4 Week | 1.08 |
| 12 Week | 18.92 |
| YTD | 32.59 |
Share Information
| Shares Outstanding (millions) | 947.48 |
| Market Capitalization (millions) | 46,985.79 |
| Short Ratio | 1.78 |
| Last Split Date | 02/16/99 |
% Price Change Relative to S&P 500
| 4 Week | -3.56 |
| 12 Week | 10.32 |
| YTD | 14.92 |
Dividend Information
| Dividend Yield | 2.22% |
| Annual Dividend | $1.10 |
| Payout Ratio | 0.41 |
| Change in Payout Ratio | 0.11 |
| Last Dividend Payout / Amount | 02/13/2013 / $0.28 |
EPS Information
| Current Quarter EPS Consensus Estimate | 0.90 |
| Current Year EPS Consensus Estimate | 3.27 |
| Estimated Long-Term EPS Growth Rate | 12.50 |
| Next EPS Report Date | 06/25/2013 |
Consensus Recommendations
| Current (1=Strong Buy, 5=Strong Sell) | 1.88 |
| 30 Days Ago | 1.88 |
| 60 Days Ago | 2.06 |
| 90 Days Ago | 2.11 |
Fundamental Ratios
P/E
| Current FY Estimate | 15.18 |
| Trailing 12 Months | 18.43 |
| PEG Ratio | 1.22 |
Price Ratios
| Price/Book | 2.47 |
| Price/Cash Flow | 13.21 |
| Price / Sales | 0.66 |
Current Ratio
| 02-28-13 | 1.38 |
| 11-30-12 | 1.30 |
| 08-31-12 | 1.23 |
Net Margin
| 02-28-13 | 2.91 |
| 11-30-12 | 2.81 |
| 08-31-12 | 2.97 |
Inventory Turnover
| 02-28-13 | 6.90 |
| 11-30-12 | 6.91 |
| 08-31-12 | 6.93 |
EPS Growth
| vs. Previous Year | 23.08% |
| vs. Previous Quarter | 65.52% |
ROE
| 02-28-13 | 14.01 |
| 11-30-12 | 13.49 |
| 08-31-12 | 14.29 |
Quick Ratio
| 02-28-13 | 0.57 |
| 11-30-12 | 0.47 |
| 08-31-12 | 0.43 |
Pre-Tax Margin
| 02-28-13 | 4.61 |
| 11-30-12 | 4.47 |
| 08-31-12 | 4.71 |
Debt-to-Equity
| 02-28-13 | 0.27 |
| 11-30-12 | 0.28 |
| 08-31-12 | 0.22 |
Sales Growth
| vs. Previous Year | -0.02% |
| vs. Previous Quarter | 7.69% |
ROA
| 02-28-13 | 7.52 |
| 11-30-12 | 7.32 |
| 08-31-12 | 7.82 |
Operating Margin
| 02-28-13 | 3.49 |
| 11-30-12 | 3.17 |
| 08-31-12 | 3.13 |
Book Value
| 02-28-13 | 20.08 |
| 11-30-12 | 19.43 |
| 08-31-12 | 19.36 |
Debt to Capital
| 02-28-13 | 21.05 |
| 11-30-12 | 21.62 |
| 08-31-12 | 18.26 |

